Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Palmitoleic acid is an omega-7 monounsaturated fatty acid that primarily modulates lipid metabolism and inflammatory pathways. This bioactive compound enhances insulin sensitivity and cardiovascular health through PPAR-alpha activation and adiponectin signaling.
Reported Benefits (Provisional)
Origin & History
Palmitoleic acid is a monounsaturated fatty acid predominantly found in macadamia nuts and sea buckthorn oil. It is extracted through cold pressing of these natural sources. The oil is then refined to increase its purity and efficacy.
Research Narrative (Provisional)
Evidence from several randomized controlled trials (RCTs) suggests palmitoleic acid can improve lipid profiles and reduce inflammation. In vitro studies support its role in skin health and metabolic regulation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Palmitoleic acid (C16:1n-7) is a monounsaturated omega-7 fatty acid comprising approximately 16 carbons with one double bond at the delta-7 position. It is not a significant source of macronutrients in isolated supplement form, but as a fatty acid it provides ~9 kcal/gram. Bioactive concentrations in supplements typically range from 200–700 mg per serving, often derived from sea buckthorn berry oil (containing 19–29% palmitoleic acid) or macadamia nut oil (16–22%). It functions primarily as a lipokine — a lipid-signaling molecule — rather than a conventional nutrient. Key bioactive roles include acting as an endogenous ligand influencing lipid metabolism, with measurable effects on hepatic fatty acid oxidation and insulin receptor signaling. It does not contain vitamins, minerals, or fiber in isolation. Bioavailability is relatively high when consumed with dietary fat due to its lipophilic nature; absorption occurs via chylomicron packaging in intestinal enterocytes. Plasma half-life is approximately 6–8 hours post-ingestion.
Reported Mechanism (Provisional)
Palmitoleic acid activates peroxisome proliferator-activated receptor alpha (PPAR-α) and stimulates adiponectin production, which enhances glucose uptake and fatty acid oxidation. It inhibits sterol regulatory element-binding protein 1c (SREBP-1c), reducing hepatic lipogenesis and improving lipid profiles. The compound also modulates inflammatory cytokines by reducing NF-κB activation and promoting anti-inflammatory eicosanoid production.
Clinical Narrative (Provisional)
Human studies on palmitoleic acid supplementation show mixed but promising results for metabolic health. A 12-week randomized controlled trial with 60 participants found 200mg daily supplementation reduced LDL cholesterol by 8-12% and improved insulin sensitivity markers. Small-scale studies (20-40 participants) demonstrate improvements in skin hydration and elasticity after 8-12 weeks of supplementation. However, larger long-term trials are needed to establish definitive therapeutic benefits and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.